Australia markets closed

Nautilus Biotechnology, Inc. (NAUT)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
2.2200-0.0350 (-1.55%)
At close: 04:00PM EDT
2.2200 0.00 (0.00%)
After hours: 04:03PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
49,304
47,251
37,672
29,352
12,432
Selling general and administrative
30,395
28,901
25,946
21,146
3,312
Total operating expenses
79,699
76,152
63,618
50,498
15,744
Operating income or loss
-79,699
-76,152
-63,618
-50,498
-15,744
Total other income/expenses net
-
-73
-122
-146
125
Income before tax
-67,440
-63,675
-57,924
-50,315
-15,619
Income from continuing operations
-67,440
-63,675
-57,924
-50,315
-15,619
Net income
-67,440
-63,675
-57,924
-50,315
-15,619
Net income available to common shareholders
-67,440
-63,675
-57,924
-50,315
-15,619
Basic EPS
-0.47
-
-0.46
-0.60
-0.13
Diluted EPS
-0.47
-
-0.46
-0.60
-0.13
Basic average shares
124,871
-
124,590
84,464
124,045
Diluted average shares
124,871
-
124,590
84,464
124,045